Merck & Co., Inc: Heart Failure trials
The registry lists 12 Heart Failure studies with Merck & Co., Inc as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 2Phase 2 5Phase 3 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)CompletedNCT05093933Phase 3Results posted
- A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)CompletedNCT02861534Phase 3Results posted
- A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)TerminatedNCT01558674Phase 1Results posted
- A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)WithdrawnNCT02364752Phase 1
- Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)CompletedNCT00729222Phase 2
- Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure PatientsCompletedNCT00652782Phase 2
- Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV TherapyCompletedNCT00443690Phase 3
- PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal FunctionCompletedNCT00354458Phase 3
- PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal FunctionCompletedNCT00328692Phase 3
- Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).CompletedNCT00159627Phase 2
- Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal ImpairmentCompletedNCT00159614Phase 2